Medtronic (MDT)Officer sold ~$319K

~$319K

Approx. value · 3,961 sh @ $80.44

37K

Holds after · shares reported

Traded

Jun 8, 2026

Filed

Jun 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
2. Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
3. Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
4. May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
5. May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.”
6. Jun 3, 2026Company filing · Form 8-K · ResultsReported its results
7. Jun 8, 2026 · this disclosureInsiderOfficer sold ~$319K of MDT shares in the open market

What came next

1. Jun 8, 2026InsiderOfficer sold ~$18K of MDT shares in the open market
2. Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
3. Jul 9, 2026FDAFDA device clearance: SmartGuard Technology; Predictive Low Glucose Technology
4. Jul 13, 2026FDARecall: MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW
5. Jul 13, 2026FDARecall: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
6. Jul 13, 2026FDARecall: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;
7. Jul 14, 2026FDAFDA device clearance: Symmetrix™ L Spinal System
8. Jul 17, 2026FDAFDA device clearance: Catalyft PL Expandable Interbody System
9. Jul 27, 2026FDAFDA device clearance: Euphora Rapid Exchange (RX) Balloon Dilatation Catheter
10. Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
11. Jul 31, 2026FDAFDA device clearance: VitalFlow Set with Balance™ Biosurface
12. Aug 13, 2026FDAFDA device clearance: BIS™ Advance pEEG Module
13. Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
14. Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
15. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
16. Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
17. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
18. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
19. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
20. Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Harry Skip Kiil, EVP & President Cardiovascular

• SEC Form 4 at Medtronic (MDT)Sep 18, 2026
• SEC Form 4 at Medtronic (MDT)Jun 10, 2026
• SEC Form 4 at Medtronic (MDT)Feb 27, 2026
• SEC Form 4 at Medtronic (MDT)Feb 27, 2026
• SEC Form 4 at Medtronic (MDT)Feb 27, 2026

The full history of Harry Skip Kiil, EVP & President Cardiovascular is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Medtronic

• SEC Form 4Sep 18, 2026
• SEC Form 144Sep 16, 2026
• House Clerk periodic transaction reportSep 1, 2026
• SEC Form 13F-HRAug 26, 2026
• House Clerk periodic transaction reportAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its MDT page.